John Doyle

7.4k total citations
195 papers, 4.7k citations indexed

About

John Doyle is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, John Doyle has authored 195 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 53 papers in Public Health, Environmental and Occupational Health and 34 papers in Oncology. Recurrent topics in John Doyle's work include Hematopoietic Stem Cell Transplantation (46 papers), Acute Lymphoblastic Leukemia research (38 papers) and Childhood Cancer Survivors' Quality of Life (24 papers). John Doyle is often cited by papers focused on Hematopoietic Stem Cell Transplantation (46 papers), Acute Lymphoblastic Leukemia research (38 papers) and Childhood Cancer Survivors' Quality of Life (24 papers). John Doyle collaborates with scholars based in Canada, United States and United Kingdom. John Doyle's co-authors include Alvin Zipursky, Lillian Sung, Adam Gassas, Lee Stern, Robert J. Klaassen, John G. Walt, Victor R. Grann, Judith S. Jacobson, Alfred I. Neugut and Dawn L. Hershman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

John Doyle

188 papers receiving 4.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Doyle 1.2k 1.1k 963 680 624 195 4.7k
Takuhiro Yamaguchi 1.3k 1.0× 1.1k 1.0× 1.4k 1.5× 1.2k 1.8× 508 0.8× 334 7.6k
John M. Weiner 668 0.5× 526 0.5× 687 0.7× 921 1.4× 284 0.5× 170 6.7k
Elizabeth Smith 1.1k 0.9× 900 0.8× 3.5k 3.6× 710 1.0× 714 1.1× 195 7.5k
M. S. Pepe 1.2k 1.0× 426 0.4× 695 0.7× 806 1.2× 190 0.3× 45 5.3k
Ian N Bruce 1.2k 1.0× 465 0.4× 1.1k 1.2× 740 1.1× 142 0.2× 310 12.1k
Anne I. Goldman 1.9k 1.5× 740 0.7× 1.2k 1.3× 557 0.8× 315 0.5× 73 5.1k
Mimi Kim 421 0.3× 1.3k 1.1× 972 1.0× 536 0.8× 379 0.6× 195 7.7k
Paul Keown 458 0.4× 1.2k 1.1× 748 0.8× 603 0.9× 1.2k 2.0× 249 8.4k
Kimme L Hyrich 3.8k 3.1× 671 0.6× 726 0.8× 515 0.8× 381 0.6× 313 12.2k
Zhezhen Jin 505 0.4× 476 0.4× 422 0.4× 1.3k 1.8× 389 0.6× 256 7.1k

Countries citing papers authored by John Doyle

Since Specialization
Citations

This map shows the geographic impact of John Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Doyle more than expected).

Fields of papers citing papers by John Doyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Doyle. The network helps show where John Doyle may publish in the future.

Co-authorship network of co-authors of John Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of John Doyle. A scholar is included among the top collaborators of John Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Doyle. John Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doyle, John, et al.. (2025). Advances in the pathophysiology, diagnosis, and management of celiac disease. BMJ. 391. e081353–e081353. 1 indexed citations
2.
Spinner, Daryl S., et al.. (2015). The evolving Global role of nontraditional payers and Reinsurance in the Reimbursement of High Cost Therapies. Value in Health. 18(3). A218–A218.
3.
Spinner, Daryl S., et al.. (2014). Global HTA Assessments of Ultra-Orphan Products: A Case Study Of Eculizumab (Soliris) and Iduronate-2-Sulfatase (Elaprase). Value in Health. 17(7). A431–A431. 1 indexed citations
4.
5.
Chen, Tao, et al.. (2014). An Analysis Of Real World Data Trends In Global Hta Markets. Value in Health. 17(3). A28–A29. 1 indexed citations
6.
Spinner, Daryl S., et al.. (2013). Health Technology Assessment of Companion Diagnostic Biomarkers as Gatekeepers for Personalized Medicine Market Access. Value in Health. 16(7). A376–A376. 1 indexed citations
7.
Doyle, John, et al.. (2012). DR1 Public Health Innovation: Biopharmaceuticals Lost in Translation?. Value in Health. 15(4). A6–A6. 2 indexed citations
8.
Doyle, John, et al.. (2011). PHP23 THE IMPACT OF MEDICARE PART D ON PRESCRIPTION VOLUME AND OUT-OF-POCKET COSTS OF MEDICALLY NECESSARY DRUGS. Value in Health. 14(3). A15–A16. 1 indexed citations
9.
Tomlinson, Deborah, Marie‐Chantal Ethier, Peter Judd, et al.. (2010). Reliability and construct validity of the oral mucositis daily questionnaire in children with cancer. European Journal of Cancer. 47(3). 383–388. 23 indexed citations
10.
Schechter, Tal, Samina Afzal, Yaron Finkelstein, et al.. (2008). Daclizumab therapy for children with corticosteroid‐resistant acute graft‐vs.‐host disease. Pediatric Transplantation. 13(3). 332–337. 3 indexed citations
11.
Bukstein, Don A., Kevin R. Murphy, Laura M. Katz, et al.. (2007). Outcomes Among a Young Population of Pediatric Asthma Patients Using Controller Therapies: Results from a Retrospective Database Analysis. Pediatric Asthma Allergy & Immunology. 20(4). 211–222. 11 indexed citations
12.
Schechter, Tal, Yaron Finkelstein, John Doyle, et al.. (2007). Pharmacokinetic Disposition and Clinical Outcomes in Infants and Children Receiving Intravenous Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 13(3). 307–314. 46 indexed citations
13.
14.
Frick, Kevin D., et al.. (2007). Direct Costs of Blindness Experienced by Patients Enrolled in Managed Care. Ophthalmology. 115(1). 11–17. 17 indexed citations
15.
Casciano, Julian, et al.. (2003). Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.. PubMed. 12(3). 47–54. 5 indexed citations
16.
Thornley, Ian, Marie-Odile Rolland, Wendy Lau, et al.. (2002). Single‐centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched‐related and matched‐unrelated donor transplants. British Journal of Haematology. 116(2). 483–490. 33 indexed citations
17.
Casciano, Julian, et al.. (2001). THE HEALTH ECONOMIC IMPACT OF ANTIDEPRESSANT USAGE FROM A PAYER'S PERSPECTIVE: A MULTINATIONAL STUDY. International Journal of Clinical Practice. 55(5). 292–299. 18 indexed citations
18.
Casciano, Julian, Steven R. Arikian, Jean‐Éric Tarride, John Doyle, & Roman Casciano. (1999). A pharmacoeconomic evaluation of major depressive disorder (Italy). Epidemiologia e Psichiatria Sociale. 8(3). 220–231. 6 indexed citations
19.
Einarson, Thomas R., Steven R. Arikian, Julian Casciano, & John Doyle. (1999). Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: A meta-analysis of randomized controlled trials. Clinical Therapeutics. 21(2). 296–308. 67 indexed citations
20.
Zipursky, Alvin, et al.. (1992). Leukemia in Down Syndrome: A Review. Pediatric Hematology and Oncology. 9(2). 139–149. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuhiro Yamaguchi Breakdown of academic impact, for papers by John M. Weiner Breakdown of academic impact, for papers by Elizabeth Smith Breakdown of academic impact, for papers by M. S. Pepe Breakdown of academic impact, for papers by Ian N Bruce Breakdown of academic impact, for papers by Anne I. Goldman Breakdown of academic impact, for papers by Mimi Kim Breakdown of academic impact, for papers by Paul Keown Breakdown of academic impact, for papers by Kimme L Hyrich Breakdown of academic impact, for papers by Zhezhen Jin
Rankless by CCL
2026